Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 313

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

Open access
Gall, Henning, Felix, Janine F., Schneck, Franziska K., Milger, Katrin, Sommer, Natascha, Voswinckel, Robert, Franco, Oscar H., Hofman, Albert, Schermuly, Ralph T., Weissmann, Norbert, Grimminger, Friedrich, Seeger, Werner, Ghofrani, Hossein A.·2017·The Journal of Heart and Lung Transplantation

Abstract

BACKGROUND: Pulmonary hypertension (PH) is a severe, progressive disease. Although 5 PH subgroups are recognized, reports on survival have focused mainly on pulmonary arterial hypertension (PAH). METHODS: Long-term transplant-free survival and its determinants were investigated in patients with PH (diagnosed by right heart catheterization) within a prospective registry at a single referral center in Giessen, Germany. RESULTS: In total, 2,067 patients were enrolled (PAH, 685 patients [33.1%]; pulmonary venous hypertension, 307 patients [14.9%]; PH due to lung diseases (LD-PH), 546 patients [26.4%; mainly interstitial lung disease and chronic obstructive pulmonary disease]; chronic thromboembolic PH, 459 patients [22.2%]; PH owing to miscellaneous/unknown causes, 70 patients [3.4%]). Median follow-up was 37 months. Differences in transplant-free survival between etiologic groups were highly significant (p < 0.001), with 1-, 3- and 5-year survival rates of 88.2%, 72.2% and 59.4%, respectively, for those with PAH compared with 79.5%, 52.7% and 38.1%, respectively, for patients with LD-PH. Patients' age, gender and 6-minute walk distance (6MWD), but not New York Heart Association (NYHA) functional class, associated significantly with survival across all PH subtypes in multivariate Cox regression analyses. CONCLUSIONS: This is the largest single-center PH cohort described so far. Some parameters used in clinical practice do not independently predict survival. Age, gender and 6MWD outperformed NYHA functional class in predicting survival across all etiologic groups.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.healun.2017.02.016

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 313

Metadata

Authors
Gall, H., Felix, J. F., Schneck, F. K., Milger, K., Sommer, N., Voswinckel, R., Franco, O. H., Hofman, A., Schermuly, R. T., Weissmann, N., Grimminger, F., Seeger, W., & Ghofrani, H. A.
Venue
The Journal of Heart and Lung Transplantation
Publisher
Elsevier BV
Published
2017-09
Volume
36
Issue
9
Pages
957-967
ISSN
1053-2498 (ISSN-L)
OpenAlex
W2587782289
Cited by
313
References
47
FWCI
21.46
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. https://app.cochat.ai/papers/10.1016/j.healun.2017.02.016
The paper
Gall, H., Felix, J. F., Schneck, F. K., Milger, K., Sommer, N., Voswinckel, R., Franco, O. H., Hofman, A., Schermuly, R. T., Weissmann, N., Grimminger, F., Seeger, W., & Ghofrani, H. A. (2017). The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2017.02.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.